![Renato Skerlj](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Renato Skerlj
Directeur Général chez
Expansion Therapeutics, Inc.
Profil
Renato T.
Skerlj is the founder of X4 Pharmaceuticals, Inc., founded in 2010 and again noted in 2014.
Current jobs include Chief Executive Officer at Rhapsogen, Inc. starting in 2026, and President, Chief Executive Officer & Director at Expansion Therapeutics, Inc. starting in 2020.
Former jobs include Vice President-Chemistry at AnorMED, Inc. from 1998 to 2006, VP-Drug Discovery & Preclinical Development at Lysosomal Therapeutics, Inc., and Senior Vice President-Research & Development at X4 Pharmaceuticals, Inc. from 2019 to 2020.
Education includes a doctorate from the University of British Columbia.
Postes actifs de Renato Skerlj
| Sociétés | Poste | Début |
|---|---|---|
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as drug discovery and development company for RNA-mediated diseases | Directeur Général | 05/10/2020 |
Anciens postes connus de Renato Skerlj
| Sociétés | Poste | Fin |
|---|---|---|
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Corporate Officer/Principal | 09/11/2006 |
| X4 PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
| X4 PHARMACEUTICALS, INC. | Fondateur | - |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Fondateur | - |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Corporate Officer/Principal | - |
Formation de Renato Skerlj
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Expansion Therapeutics, Inc.
Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as drug discovery and development company for RNA-mediated diseases | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
